Unregulated p100 processing into p52 results in multiple myeloma and other lymphoid malignancies, which is detrimental to normal cellular function (Courtois and Gilmore, 2006; Annunziata et al., 2007; Keats et al., 2007). The gene discussed is NFKB2; the disease is plasma cell myeloma.